Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7435)
All Articles published online
|
Publishing Process of This Article
|
Dec 26, 2019 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wu SZ, Liang X, Geng J, Zhang MB, Xie N, Su XY. Hydroxychloroquine-induced renal phospholipidosis resembling Fabry disease in undifferentiated connective tissue disease: A case report. World J Clin Cases 2019; 7(24): 4377-4383 [PMID: 31911921 DOI: 10.12998/wjcc.v7.i24.4377] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v7/i24/4377.htm |
| Number | Citing Articles |
| 1 |
Alessandra Ida Celia, Roberta Priori, Bruna Cerbelli, Francesca Diomedi-Camassei, Vincenzo Leuzzi, Rossana Scrivo, Cristiano Alessandri, Giulia d’Amati, Fabrizio Conti. “Protenuria in SLE: Is it always lupus?”. Lupus 2021; 30(4): 664 doi: 10.1177/0961203320983458
|
| 2 |
Johanna Schneider, Bernd Jaenigen, Dirk Wagner, Siegbert Rieg, Daniel Hornuss, Paul M. Biever, Winfried V. Kern, Gerd Walz, Yu Ru Kou. Therapy with lopinavir/ritonavir and hydroxychloroquine is associated with acute kidney injury in COVID-19 patients. PLOS ONE 2021; 16(5): e0249760 doi: 10.1371/journal.pone.0249760
|
| 3 |
|
| 4 |
Takahiro Tsukimura, Tomoko Shiga, Koki Saito, Yasuhiro Ogawa, Hitoshi Sakuraba, Tadayasu Togawa. Does administration of hydroxychloroquine/amiodarone accelerate accumulation of globotriaosylceramide and globotriaosylsphingosine in Fabry mice?. Molecular Genetics and Metabolism Reports 2021; 28: 100773 doi: 10.1016/j.ymgmr.2021.100773
|
| 5 |
Pushpanjali R. Ojha, Rakesh Kumar. Intraepithelial Inclusions on Urinalysis Screening among COVID-19 Cases: Are they Covicytes?—A Hospital-Based Cohort Study with Narrative Review. Journal of Cytology 2024; 41(1): 34 doi: 10.4103/joc.joc_102_23
|
| 6 |
Takahiro Tsukimura, Koki Saito, Tomoko Shiga, Yasuhiro Ogawa, Hitoshi Sakuraba, Tadayasu Togawa. Does administration of hydroxychloroquine/amiodarone affect the efficacy of enzyme replacement therapy for Fabry mice?. Molecular Genetics and Metabolism Reports 2024; 39: 101079 doi: 10.1016/j.ymgmr.2024.101079
|
| 7 |
Pasquale Esposito, Carmela Caputo, Monica Repetto, Alberto Somaschini, Bellone Pietro, Paolo Colomba, Carmela Zizzo, Angelica Parodi, Valentina Zanetti, Marco Canepa, Virginia Eustachi, Francesca Sanguineri, Paola Mandich, Francesca Viazzi. Diagnosing Fabry nephropathy: the challenge of multiple kidney disease. BMC Nephrology 2023; 24(1) doi: 10.1186/s12882-023-03388-8
|
| 8 |
Luke R. Gagnon, Chandu Sadasivan, Haran Yogasundaram, Gavin Y. Oudit. Review of Hydroxychloroquine Cardiotoxicity: Lessons From the COVID-19 Pandemic. Current Heart Failure Reports 2022; 19(6): 458 doi: 10.1007/s11897-022-00581-y
|
| 9 |
Romain Muller. Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities. Rheumatology International 2021; 41(7): 1189 doi: 10.1007/s00296-021-04868-6
|
| 10 |
Mohammad Obeidat, Alexandra L Isaacson, Stephanie J. Chen, Marina Ivanovic, Danniele Holanda. Zebra-like bodies in COVID-19: is phospholipidosis evidence of hydroxychloroquine induced acute kidney injury?. Ultrastructural Pathology 2020; 44(4-6): 519 doi: 10.1080/01913123.2020.1850966
|
| 11 |
Rand Saba, Ugochukwu Umeh, Joshua Davis. Treatment of SARS-CoV-2 (COVID-19): A safety perspective. World Journal of Pharmacology 2021; 10(1): 1-32 doi: 10.5497/wjp.v10.i1.1
|
| 12 |
Amélie Friederike Menke, Barbara Heitplatz, Veerle Van Marck, Hermann Pavenstädt, Ulrich Jehn. Hydroxychloroquine-Induced Renal Phospholipidosis: Case Report and Review of Differential Diagnoses. Case Reports in Nephrology and Dialysis 2024; 14(1): 20 doi: 10.1159/000536448
|
| 13 |
Pharmacological Treatment Options for Coronavirus Disease-19 in Renal Patients. International Journal of Nephrology 2021; 2021: 1 doi: 10.1155/2021/4078713
|
| 14 |
Alina Dima, Ciprian Jurcut, François Chasset, Renaud Felten, Laurent Arnaud. Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge. Therapeutic Advances in Musculoskeletal Disease 2022; 14 doi: 10.1177/1759720X211073001
|